Clinical Trial Update: Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2 [Phase 3]

View source ↗

Summary

Phase 3 trial update for lateral ridge augmentation using autogenous or xenogenic bone blocks loaded with rhBMP-2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Missing Teeth

Drugs mentioned

• recombinant human bone morphogenic protein 2 (rhBMP-2)

Snippet

Sponsor: University of Zurich | Conditions: Missing Teeth | Phase 3 | Status: COMPLETED